Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,740,239,592
-
Number of holders
-
2767
-
Total 13F shares, excl. options
-
1,278,700,730
-
Shares change
-
-7,780,106
-
Total reported value, excl. options
-
$179,840,586,022
-
Value change
-
-$1,005,861,355
-
Put/Call ratio
-
1.03%
-
Number of buys
-
1,207
-
Number of sells
-
-1,018
-
Price
-
$140.74
Significant Holders of ABBOTT LABORATORIES - Common Stock (ABT) as of Q4 2021
2,937 filings reported holding ABT - ABBOTT LABORATORIES - Common Stock as of Q4 2021.
ABBOTT LABORATORIES - Common Stock (ABT) has 2,767 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,278,700,730 shares
of 1,740,239,592 outstanding shares and own 73.48% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (149,152,264 shares), BlackRock Inc. (137,155,602 shares), Capital Research Global Investors (84,125,029 shares), STATE STREET CORP (74,322,051 shares), Capital International Investors (52,397,671 shares), MORGAN STANLEY (29,322,496 shares), GEODE CAPITAL MANAGEMENT, LLC (27,906,282 shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (26,698,119 shares), NORTHERN TRUST CORP (25,523,579 shares), and BANK OF AMERICA CORP /DE/ (25,093,645 shares).
This table shows the top 2767 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.